AnatomyOrganismsChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesInformation Science
Nucleotides, CyclicProtein Kinase CProtein KinasesCyclic Nucleotide Phosphodiesterases, Type 1Cyclic GMPCyclic AMPCyclic AMP-Dependent Protein Kinases3',5'-Cyclic-AMP PhosphodiesterasesNucleotides2',3'-Cyclic-Nucleotide PhosphodiesterasesCalcium-Calmodulin-Dependent Protein KinasesProtein-Serine-Threonine KinasesPhosphorylationProtein Kinase InhibitorsMitogen-Activated Protein KinasesMolecular Sequence DataMAP Kinase Signaling SystemCyclic Nucleotide Phosphodiesterases, Type 3Enzyme Activationp38 Mitogen-Activated Protein KinasesPhosphatidylinositol 3-KinasesPhosphoric Diester HydrolasesAmino Acid SequencePhosphodiesterase InhibitorsCyclic Nucleotide Phosphodiesterases, Type 2Mitogen-Activated Protein Kinase 1Signal TransductionIsoenzymesCyclic GMP-Dependent Protein KinasesKineticsProtein Kinase C-alphaMitogen-Activated Protein Kinase KinasesProtein Kinase C-deltaMitogen-Activated Protein Kinase 3Dibutyryl Cyclic GMPCyclic Nucleotide Phosphodiesterases, Type 4JNK Mitogen-Activated Protein KinasesAMP-Activated Protein KinasesBase Sequence1-Methyl-3-isobutylxanthineCalciumCell LineCells, CulturedTetradecanoylphorbol AcetateEnzyme InhibitorsProtein Kinase C-epsilonProtein Kinase C betaCyclic Nucleotide-Gated Cation Channelssrc-Family Kinases3',5'-Cyclic-GMP PhosphodiesterasesMutationProtein BindingCloning, MolecularProtein-Tyrosine KinasesBucladesineBinding SitesCyclic Nucleotide Phosphodiesterases, Type 7CalmodulinSubstrate SpecificityCDC2 Protein KinaseCyclic Nucleotide Phosphodiesterases, Type 5Cyclic IMPRNA, MessengerAdenine NucleotidesCasein Kinase IIAdenosine TriphosphateCalcium-Calmodulin-Dependent Protein Kinase Type 28-Bromo Cyclic Adenosine MonophosphateCattleTransfectionMAP Kinase Kinase KinasesSequence Homology, Amino AcidPhosphoproteinsRecombinant ProteinsTheophyllineeIF-2 KinaseBlotting, WesternDose-Response Relationship, Drugp21-Activated KinasesIsoquinolinesSerineProtein Structure, TertiaryPolymorphism, Single NucleotideMAP Kinase Kinase 1ColforsinExtracellular Signal-Regulated MAP KinasesGuanine NucleotidesTranscription, GeneticRibosomal Protein S6 KinasesDNAProto-Oncogene Proteins c-aktProto-Oncogene ProteinsCasein KinasesTime FactorsAdenylate CyclasePurinonesMAP Kinase Kinase 4Cyclin-Dependent KinasesDiglyceridesPhorbol 12,13-Dibutyrate

Kinase phosphorylation: Keeping it all in the family. (1/7)

The identification of PDK1 as a kinase that phosphorylates the AGC family of kinases led to a hunt for 'PDK2', a hypothetical regulated kinase(s) that would be required for full activation of the AGC kinases. Recent findings suggest that the elusive PDK2 may actually be a familiar kinase with an atypical associate.  (+info)

Phosphorylation of type-1 inositol 1,4,5-trisphosphate receptors by cyclic nucleotide-dependent protein kinases: a mutational analysis of the functionally important sites in the S2+ and S2- splice variants. (2/7)

Inositol 1,4,5-trisphosphate receptors (InsP3R) are the major route of intracellular calcium release in eukaryotic cells and as such are pivotal for stimulation of Ca2+-dependent effectors important for numerous physiological processes. Modulation of this release has important consequences for defining the particular spatio-temporal characteristics of Ca2+ signals. In this study, regulation of Ca2+ release by phosphorylation of type-1 InsP3R (InsP3R-1) by cAMP (PKA)- and cGMP (PKG)-dependent protein kinases was investigated in the two major splice variants of InsP3R-1. InsP3R-1 was expressed in DT-40 cells devoid of endogenous InsP3R. In cells expressing the neuronal, S2+ splice variant of the InsP3R-1, Ca2+ release was markedly enhanced when either PKA or PKG was activated. The sites of phosphorylation were investigated by mutation of serine residues present in two canonical phosphorylation sites present in the protein. Potentiated Ca2+ release was abolished when serine 1755 was mutated to alanine (S1755A) but was unaffected by a similar mutation of serine 1589 (S1589A). These data demonstrate that Ser-1755 is the functionally important residue for phosphoregulation by PKA and PKG in the neuronal variant of the InsP3R-1. Activation of PKA also resulted in potentiated Ca2+ release in cells expressing the non-neuronal, S2- splice variant of the InsP3R-1. However, the PKA-induced potentiation was still evident in S1589A or S1755A InsP3R-1 mutants. The effect was abolished in the double (S1589A/S1755A) mutant, indicating both sites are phosphorylated and contribute to the functional effect. Activation of PKG had no effect on Ca2+ release in cells expressing the S2- variant of InsP3R-1. Collectively, these data indicate that phosphoregulation of InsP3R-1 has dramatic effects on Ca2+ release and defines the molecular sites phosphorylated in the major variants expressed in neuronal and peripheral tissues.  (+info)

Ca(2+)-dependent conformational changes in guanylyl cyclase-activating protein 2 (GCAP-2) revealed by site-specific phosphorylation and partial proteolysis. (3/7)

Guanylyl cyclase-activating proteins (GCAPs) are calcium sensor proteins of the EF-hand superfamily that inhibit retinal photoreceptor membrane guanylyl cyclase (retGC) in the dark when they bind Ca(2+) but activate retGC when Ca(2+) dissociates from GCAPs in response to light stimulus. We addressed the difference in exposure of GCAP-2 structure to protein kinase and a protease as indicators of conformational change caused by binding and release of Ca(2+). We have found that unlike its homolog, GCAP-1, the C terminus of GCAP-2 undergoes phosphorylation by cyclic nucleotide-dependent protein kinases (CNDPK) present in the retinal extract and rapid dephosphorylation by the protein phosphatase PP2C present in the retina. Inactivation of the CNDPK phosphorylation site in GCAP-2 by substitutions S201G or S201D, as well as phosphorylation or thiophosphorylation of Ser(201), had little effect on the ability of GCAP-2 to regulate retGC in reconstituted membranes in vitro. At the same time, Ca(2+) strongly inhibited phosphorylation of the wild-type GCAP-2 by retinal CNDPK but did not affect phosphorylation of a constitutively active Ca(2+)-insensitive GCAP-2 mutant. Partial digestion of purified GCAP-2 with Glu-C protease revealed at least two sites that become exposed or constrained in a Ca(2+)-sensitive manner. The Ca(2+)-dependent conformational changes in GCAP-2 affect the areas around Glu(62) residue in the entering helix of EF-hand 2, the areas proximal to the exiting helix of EF-hand 3, and Glu(136)-Glu (138) between EF-hand 3 and EF-hand 4. These changes also cause the release of the C-terminal Ser(201) from the constraint caused by the Ca(2+)-bound conformation.  (+info)

KMUP-1 activates BKCa channels in basilar artery myocytes via cyclic nucleotide-dependent protein kinases. (4/7)

This study investigated whether KMUP-1, a synthetic xanthine-based derivative, augments the delayed-rectifier potassium (K(DR))- or large-conductance Ca2+-activated potassium (BKCa) channel activity in rat basilar arteries through protein kinase-dependent and -independent mechanisms. Cerebral smooth muscle cells were enzymatically dissociated from rat basilar arteries. Conventional whole cell, perforated and inside-out patch-clamp electrophysiology was used to monitor K+- and Ca2+ channel activities. KMUP-1 (1 microM) had no effect on the K(DR) current but dramatically enhanced BKCa channel activity. This increased BKCa current activity was abolished by charybdotoxin (100 nM) and iberiotoxin (100 nM). Like KMUP-1, the membrane-permeable analogs of cGMP (8-Br-cGMP) and cAMP (8-Br-cAMP) enhanced the BKCa current. BKCa current activation by KMUP-1 was markedly inhibited by a soluble guanylate cyclase inhibitor (ODQ 10 microM), an adenylate cyclase inhibitor (SQ 22536 10 microM), competitive antagonists of cGMP and cAMP (Rp-cGMP, 100 microM and Rp-cAMP, 100 microM), and cGMP- and cAMP-dependent protein kinase inhibitors (KT5823, 300 nM and KT5720, 300 nM). Voltage-dependent L-type Ca2+ current was significantly suppressed by KMUP-1 (1 microM), and nearly abolished by a calcium channel blocker (nifedipine, 1 microM). In conclusion, KMUP-1 stimulates BKCa currents by enhancing the activity of cGMP-dependent protein kinase, and in part this is due to increasing cAMP-dependent protein kinase. Physiologically, this activation would result in the closure of voltage-dependent calcium channels and the relaxation of cerebral arteries.  (+info)

Osmotic regulation of betaine homocysteine-S-methyltransferase expression in H4IIE rat hepatoma cells. (5/7)

Cell hydration changes critically affect liver metabolism and gene expression. In the course of gene expression studies using nylon cDNA-arrays we found that hyperosmolarity (405 mosmol/l) suppressed the betaine-homocysteine methyltransferase (Bhmt) mRNA expression in H4IIE rat hepatoma cells. This was confirmed by Northern blot and real-time quantitative RT-PCR analysis, which in addition unraveled a pronounced induction of Bhmt mRNA expression by hypoosmotic (205 mosmol/l) swelling. Osmotic regulation of Bhmt mRNA expression was largely paralleled at the levels of Bhmt protein and enzymatic activity. Like hyperosmotic NaCl, hyperosmotic raffinose but not hyperosmotic urea suppressed Bhmt mRNA expression, suggesting that cell shrinkage rather than increased ionic strength or hyperosmolarity per se is the trigger. Hypoosmolarity increased the expression of a reporter gene driven by the entire human BHMT promoter, whereas destabilization of BHMT mRNA was observed under hyperosmotic conditions. Osmosensitivity of Bhmt mRNA expression was impaired by inhibitors of tyrosine kinases and cyclic nucleotide-dependent kinases. The osmotic regulation of BHMT may be part of a cell volume-regulatory response and additionally lead to metabolic alterations that depend on the availability of betaine-derived methyl groups.  (+info)

Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action. (6/7)

 (+info)

Alcohol stimulates ciliary motility of isolated airway axonemes through a nitric oxide, cyclase, and cyclic nucleotide-dependent kinase mechanism. (7/7)

 (+info)